IVD Medical to acquire B-Soft stake, expand AI healthcare footprint

IVD Medical Holding Limited announced on November 16, 2025, a discloseable transaction involving the acquisition of a 6.23% stake in B-Soft Co., Ltd. for an aggregate cash consideration of 500 million yuan. The acquisition price is 5.18 yuan per Target Share for 96,525,096 A shares. The consideration will be settled in four installments, with the first installment of 155 million yuan, representing 31% of the total, due within five business days upon satisfaction of specified conditions.

Concurrently, the vendor, Mr. Ge Hang, will entrust his voting rights attached to 155,780,282 A shares (10.06% of total capital) to the purchaser, starting November 12, 2025. Additionally, the purchaser and a private fund will entrust voting rights for 40,000,000 A shares (2.58% of total capital), starting November 14, 2025. Following completion of the acquisition and the entrustment of voting rights, IVD Medical is expected to hold voting rights representing approximately 12.64% of B-Soft's issued shares.

The acquisition is conditional upon various factors, including regulatory approvals and satisfaction of payment conditions. The company plans to fund the 500 million yuan consideration through internal resources or a bank loan. This move is aligned with IVD Medical's strategy to integrate AI algorithms into healthcare, with B-Soft becoming a key subsidiary and its financial results consolidated into the Group’s statements.